Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used in a broad range of interventional medical specialties. The company is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. They focus on less-invasive LStreatments, aiming to reduce risk, cost, and recovery time for patients.
Serves as the global corporate headquarters, housing executive leadership, global strategic planning, key research and development facilities, and central administrative functions.
A modern, expansive campus featuring state-of-the-art research and development labs, collaborative workspaces, training facilities, and employee amenities like fitness centers and cafes.
Characterized by a strong emphasis on innovation, collaboration, and a patient-first mindset. Employees are driven by the company's mission to advance science for life, fostering a culture of high performance, integrity, and continuous improvement.
The Marlborough campus is a critical hub for Boston Scientific's global operations, symbolizing its commitment to innovation in the medical device industry and its significant presence in the Massachusetts life sciences cluster.
Boston Scientific has a significant global footprint, operating in approximately 130 countries. This includes extensive sales and distribution networks, multiple manufacturing facilities, and research and development centers across the Americas, Europe, Asia-Pacific, Middle East, and Africa. The company supports healthcare professionals and patients worldwide with its diverse portfolio of medical devices and solutions.
300 Boston Scientific Way
Marlborough
Massachusetts
USA
Address: One Scimed Place, Maple Grove, MN 55311-1566, USA
Serves as a center of excellence for key product lines and supports both North American and global markets with advanced manufacturing and R&D capabilities.
Address: Cashel Road, Clonmel, Co. Tipperary, Ireland
Key site for European operations, supply chain management, and manufacturing for products serving EMEA and other international markets. Reflects strong investment in Ireland's MedTech sector.
Address: Shinjuku M-Square, 20-2, Nishi-Shinjuku 6-chome, Shinjuku-ku, Tokyo 163-1135 (Note: This is their main Japan office, specific R&D/Mfg might be elsewhere but this is a key hub. Yokohama also has presence)
Drives growth and market penetration in the Asia-Pacific region, supporting sales, marketing, clinical research, and product development adapted to regional healthcare needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Boston Scientific' leadership includes:
Boston Scientific has been backed by several prominent investors over the years, including:
In the past year, Boston Scientific has seen key leadership transitions, including a new head of Human Resources and a new leadership role in the Americas for Interventional Cardiology and Peripheral Interventions.
Discover the tools Boston Scientific uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Boston Scientific commonly uses the 'firstname.lastname@bostonscientific.com' email format for its employees. Variations might exist, but this is a widely observed pattern.
firstname.lastname@bostonscientific.com
Format
jane.doe@bostonscientific.com
Example
90%
Success rate
Boston Scientific Newsroom • May 2, 2024
Boston Scientific announced it has completed its acquisition of Axon Therapies, Inc., developer of a novel therapy for heart failure. This acquisition expands Boston Scientific's portfolio in the area of cardiovascular treatments....more
Boston Scientific Newsroom • April 24, 2024
Boston Scientific reported strong financial results for the first quarter of 2024, with net sales of $3.856 billion, growing 13.8% on a reported basis, compared to the prior year period. The company also raised its full-year 2024 sales and EPS guidance....more
Boston Scientific Newsroom • April 7, 2024
Positive late-breaking clinical trial results for the AGENT Drug-Coated Balloon (DCB) were presented, showing superiority over uncoated balloon angioplasty for treating coronary in-stent restenosis. The AGENT DCB is a new device therapy under FDA review....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Boston Scientific, are just a search away.